VenoStent is developing SelfWrap, a bioabsorbable polymer vascular wrap designed to reduce failures at dialysis access sites. This technology aims to enhance patient outcomes in vascular surgery by providing flexible support that promotes healing and stability.
Funding
$29.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ICNS+1Founders
Product
Problem
Failure rates at dialysis access sites remain high, leading to repeated interventions and increased healthcare costs. Current solutions often lack the flexibility and biointegration needed to promote long-term healing and stability of the vascular anastomosis.
Solution
VenoStent is developing SelfWrap, a bioabsorbable polymer vascular wrap designed to reduce failures at dialysis access sites. SelfWrap provides flexible external support to the blood vessel, promoting improved healing and stability at the surgical site. The bioabsorbable material is designed to be gradually absorbed by the body, leaving the native vessel to function naturally. This technology aims to improve vascular surgery outcomes by providing a novel approach to dialysis access site reinforcement.
Target Audience
The primary target audience includes vascular surgeons and interventional radiologists who perform dialysis access procedures, as well as the patients requiring hemodialysis.
Features
- Bioabsorbable polymer composition for gradual degradation and natural vessel remodeling
- Flexible wrap design to provide dynamic support without restricting vessel movement
- Designed to reduce stenosis and thrombosis at the anastomosis site
- Intended to improve patency rates and reduce the need for re-interventions